|
|
||||||||
1Department of Medicine, Cardiovascular Center, and Veterans Administration Medical Center, Medical College of Wisconsin, Milwaukee, Wisconsin; 2Second Department of Internal Medicine, Akita University School of Medicine, Akita; and 3Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine, Sapporo, Japan
Submitted 14 June 2004 ; accepted in final form 13 December 2004
Adenosine is a key myocardial metabolite that elicits coronary vasodilation in a variety of pathophysiological conditions. We examined the mechanism of adenosine-induced vasodilation in coronary arterioles from patients with heart disease. Human coronary arterioles (HCAs) were dissected from pieces of the atrial appendage obtained at the time of cardiac surgery and cannulated for the measurement of internal diameter with videomicroscopy. Adenosine-induced vasodilation was not inhibited by endothelial denudation, but A2 receptor antagonism with 3,7-dimethyl-1-propargylxanthine and adenylate cyclase (AC) inhibition with SQ22536 significantly attenuated the dilation. In contrast, A1 receptor antagonism with 8-cyclopentyl-1,3-dipropylxanthine significantly augmented the sensitivity to adenosine. Moreover, dilation to A2a receptor activation with 2-p-(2-carboxyethyl)phenethylamino-5'-N-ethylcarboxamido-adenosine hydrochloride was reduced by the A1 receptor agonist (2S)-N6-(2-endo-norbornyl)adenosine. The nonspecific calcium-activated potassium (KCa) channel blocker tetrabutylammonium attenuated adenosine-induced dilation, as did the intermediate-conductance KCa blocker clotrimazole. Neither the large-conductance KCa blocker iberiotoxin nor small-conductance KCa blocker apamin altered the dilation. In conclusion, adenosine endothelium independently dilates HCAs from patients with heart disease through a receptor-mediated mechanism that involves the activation of intermediate-conductance KCa channels via an AC signaling pathway. The roles of A1 and A2 receptor subtypes are opposing, with the former being inhibitory to AC-mediated dilator actions of the latter. These observations identify unique fundamental physiological characteristics of the human coronary circulation and may help to target the use of novel adenosine analogs for vasodilation in perfusion imaging or suggest new strategies for myocardial preconditioning.
receptors; potassium channels; microcirculation
This article has been cited by other articles:
![]() |
A. R. Pries, H. Habazettl, G. Ambrosio, P. R. Hansen, J. C. Kaski, V. Schachinger, H. Tillmanns, G. Vassalli, I. Tritto, M. Weis, et al. A review of methods for assessment of coronary microvascular disease in both clinical and experimental settings Cardiovasc Res, June 25, 2008; (2008) cvn136v2. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. R. Ansari, A. Nadeem, M. A. H. Talukder, S. Sakhalkar, and S. J. Mustafa Evidence for the involvement of nitric oxide in A2B receptor-mediated vasorelaxation of mouse aorta Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H719 - H725. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. E. Tawfik, B. Teng, R. R. Morrison, J. Schnermann, and S. J. Mustafa Role of A1 adenosine receptor in the regulation of coronary flow Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H467 - H472. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |